August 15-19: Arendalsuka 2022

Many useful and inspiring meeting places and debate arenas during Arendalsuka, 15-19.8 2022.

Aamodt participated in the panel of several meetings.

The Dagens Medisin Arena on the "Blåresept-ordningen":

Panel at Dagens Medisin Arena – from left:

Einar Andreassen, fungerende områdedirektør, Legemiddelverket (SLV)

Hege Edvardsen, seniorrådgiver i Legemiddelindustrien (LMI)

Seher Aydar, stortingsrepresentant for Rødt og medlem i Helse- og omsorgskomiteen

Anne Hege Aamodt

A meeting arranged by Hodepine Norge and Abbvie on headache management in Norway:

From left: Tine Poole – member of board, Hodepine Norge, Laila Mathisen – secretary general in Hodepine Norge, Kari Løvendahl Mogstad – general practitioner, associate professor, NTNU and Anne Hege Aamodt

There were also important meetings with the user organizations and companies involved in our research projects - Hodepine Norge, Blindeforbundet, LHL Hjerneslag and Ledidi. 

From left: Anne Hege Aamodt, Kari Løvendahl Mogstad – general practitioner, associate professor, NTNU, Laila Mathisen – secretary general in Hodepine Norge, Tine Poole – member of board, Hodepine Norge, and health economist Erland Skogli fra Menon Economics

Meeting with Ledidi – Jakob Markussen and Hanne Støre Valeur

Meeting with The Norwegian Association of the Blind and Partially Sighted – NABP - Norges Blindeforbund (and LHL Hjerneslag – Head of Research in Blindeforbundet Inga-Britt Kjellevold Haugen and user representative of both Blindeforbundet and LHL Hjerneslag Arild Hagen

The NorHEAD stand at Arendalsuka with
Anne Hege Aamodt, Professor Erling Tronvik - the centre Director and Jaya Syltern Thomilson – daily manager of NorHEAD.

Scroll to top

Recent publications

Leone MA, Helbok R, Bianchi E, Yasuda CL, Konti M, Ramankulov D, Lolich M, Lovrencic-Huzjan A, Kovács T, Armon C, Cotelli MS, Cavallieri F, Grosu O, Kiteva-Trenchevska G, Rodriguez-Leyva I, Boldingh M, Brola W, Maia LF, de Seabra MML, Davidescu EI, Popescu BO, Kopishinskaia S, Bassetti CLA, Moro E, ENERGY Study Group (§) (2024)
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry
J Neurol (in press)
DOI 10.1007/s00415-024-12212-8, PubMed 38436682

Gilhus NE, Andersen H, Andersen LK, Boldingh M, Laakso S, Leopoldsdottir MO, Madsen S, Piehl F, Popperud TH, Punga AR, Schirakow L, Vissing J (2024)
Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
Eur J Neurol, 31 (5), e16229
DOI 10.1111/ene.16229, PubMed 38321574

de Jonge JC, Sluis WM, Reinink H, Bath PM, Woodhouse LJ, Zweedijk B, van de Beek D, Aamodt AH, Alpers I, Ciccone A, Csiba L, Demotes J, Kõrv J, Kurkowska-Jastrzebska I, Dawson J, Macleod MR, Ntaios G, Poli S, Milionis H, Ricci S, Cenciarelli S, Candelaresi P, de Bruijn SF, Pathansali R, Krishnan K et al. (2023)
Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessment
Lancet Reg Health Eur, 36, 100782
DOI 10.1016/j.lanepe.2023.100782, PubMed 38074444